Cohort Profile: The International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study
Jason Grebely(UNSW Sydney), Kimberly Page(University of New Mexico), Margaret Hellard(The Alfred Hospital), Barbara McGovern(Tufts Medical Center), Naglaa H. Shoukry(Centre Hospitalier de l’Université de Montréal), Maria Prins(University of Amsterdam), Gregory J. Dore(UNSW Sydney), Meghan D. Morris(University of California, San Francisco), Lisa Maher(UNSW Sydney), Andrea L. Cox(Johns Hopkins University), Thomas Rice(University of Exeter), Arthur Y Kim(Harvard University), Georg M. Lauer(Broad Institute), Julie Bruneau(Novem (Netherlands)), Andrew R. Lloyd(Oregon Health & Science University)
Cited by 54
Related Papers
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study
|BMJ|2006|845
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
|Clinical Infectious Diseases|2014|773
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Relationship between T Cell Activation and CD4 <sup>+</sup> T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
|The Journal of Infectious Diseases|2007|639